# Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

> **NCT00121121** · PHASE1 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 70 (—)

## Conditions studied

- HIV Infections
- HIV Seronegativity

## Interventions

- **BIOLOGICAL:** Lipopeptides LIPO-4

## Key facts

- **NCT ID:** NCT00121121
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 70 (—)
- **Last updated:** 2007-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121121, "Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00121121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*